Evidence map›Paper›PMID 20439918›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

A role for IL-1 receptor-associated kinase-M in prostaglandin E2-induced immunosuppression post-bone marrow transplantation.

Leah L N Hubbard, Megan N Ballinger, Peedikayil E Thomas, Carol A Wilke, Theodore J Standiford, Koichi S Kobayashi, Richard A Flavell, Bethany B Moore

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The IRAK-M death domain: a tale of three surfaces.Frontiers in molecular biosciences · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Prostaglandin EPharmacology & therapeutics · 2018
    Review
  10. Elevated prostaglandin EMucosal immunology · 2018
    Article
  11. Article
  12. Article
  13. Prostaglandin EFrontiers in physiology · 2017
    Review
  14. Targeting Inhibitor of Apoptosis Proteins Protects from Bleomycin-Induced Lung Fibrosis.American journal of respiratory cell and molecular biology · 2016
    Article
  15. Article
  16. Article
  17. The structure function of the death domain of human IRAK-M.Cell communication and signaling : CCS · 2014
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Leah L N HubbardGraduate Program in Immunology, University of Michigan, Ann Arbor, MI 48109, USA.
Megan N Ballinger
Peedikayil E Thomas
Carol A Wilke
Theodore J Standiford
Koichi S Kobayashi
Richard A Flavell
Bethany B Moore
Pulmonary and Critical Care Associates · USUniversity of Michigan · USHarvard University · USHoward Hughes Medical Institute · US

Funding

SCCOR in Translational Research in Acute Lung InjuryP50HL074024 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HYZY, ROBERT C · 2003 to 2007
$13.5M
RESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8M
Role of TLR9 in Lung Antibacterial Host DefenseR01HL057243 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI STANDIFORD, THEODORE J. · 1997 to 2011
$3.6M
PGE2 Regulation of Host Defense post-BMTR01AI065543 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOORE, BETHANY B. · 2007 to 2011
$1.9M
Nod2-mediated regulation of intestinal homeostasisR01DK074738 · NIDDK · DANA-FARBER CANCER INST · PI KOBAYASHI, KOICHI S · 2007 to 2011
$1.4M
HSCT-induced changes that impair lung innate immunityR56AI065543 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOORE, BETHANY B. · 2012 to 2012
$363k
Howard Hughes Medical InstituteNHLBI NIH HHS HL25243NHLBI NIH HHS P50 HL074024NHLBI NIH HHS R01 HL057243NIAID NIH HHS AI065543NIAID NIH HHS R01 AI065543NIAID NIH HHS R56 AI065543NIAID NIH HHS T32 AI007413NIDDK NIH HHS R01 DK074738
6 · The paper itself

Abstract

Following immune reconstitution, hematopoietic stem cell transplant patients often display reduced immune function and are especially susceptible to lung infections. In a mouse model of syngeneic bone marrow transplantation (BMT), we previously reported that PGE(2) is overproduced in lungs of BMT mice, significantly impairing host defense against Pseudomonas aeruginosa. This impairment in host defense post-BMT is also marked by diminished alveolar macrophage (AM) phagocytosis, bacterial killing, and production of TNF-alpha and cysteinyl leukotrienes. However, a mechanism by which overproduction of PGE(2) suppresses pulmonary host defense post-BMT is unknown. As IL-1R-associated kinase (IRAK)-M is a known inhibitor of MyD88-dependent IL-1R/TLR signaling and macrophage function, we sought to determine whether IRAK-M is involved in PGE(2)-induced immunosuppression post-BMT. We found that IRAK-M expression is elevated 3.5-fold in BMT AMs relative to control AMs, and this is related to AM overproduction of PGE(2). Furthermore, genetic ablation of IRAK-M in the bone marrow of BMT mice restores host defense against P. aeruginosa. Despite AM overproduction of PGE(2) and elevated E prostanoid 2 receptor expression, AM phagocytosis, killing, and production of cysteinyl leukotrienes and TNF-alpha are restored in the absence of IRAK-M post-BMT. Also, treatment with PGE(2) does not inhibit AM phagocytosis in the absence of IRAK-M. These data suggest that the absence of IRAK-M in the hematopoietic compartment post-BMT enhances pulmonary host defense and mitigates AM sensitivity to the inhibitory effects of PGE(2). Therefore, strategies to limit IRAK-M elevation post-BMT may be efficacious in reducing patient susceptibility to infection.

Indexed as

AnimalsBone Marrow TransplantationCell SeparationDinoprostoneEnzyme-Linked Immunosorbent AssayFlow CytometryImmune ToleranceInterleukin-1 Receptor-Associated KinasesMacrophages, AlveolarMiceMice, Inbred C57BLPseudomonas InfectionsReverse Transcriptase Polymerase Chain ReactionDinoprostoneInterleukin-1 Receptor-Associated KinasesIrak3 protein, mouse

Identifiers

PMID20439918
PMCPMC4040537
OpenAlexW1919688027

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.